Gamma-aminobutyric acid type A receptor (GABA-A receptor) benzodiazepine binding site (GABA-A receptor BZD site)

The Gamma-aminobutyric acid type A (GABA-A) receptor benzodiazepine binding site is a distinct allosteric pocket located at the interface of the alpha (α1, α2, α3, or α5) and gamma (γ2) subunits of the heteropentameric GABA-A receptor complex (Sigel & Steinmann, 2012). As the principal inhibitory neurotransmitter receptor in the mammalian central nervous system, the GABA-A receptor functions as a ligand-gated chloride channel that regulates neuronal firing and excitability (StatPearls, 2023). Benzodiazepines and related "Z-drugs" bind to this specific site to act as positive allosteric modulators, increasing the receptor's affinity for GABA and the frequency of chloride channel opening (PubMed, PMC3429571). This modulation results in anxiolytic, sedative, hypnotic, anticonvulsant, and muscle relaxant effects, making it a cornerstone for treating various neuropsychiatric conditions. However, chronic activation of this site is associated with compensatory changes leading to tolerance, physical dependence, and a potentially severe withdrawal syndrome (StatPearls, 2023).

Other names

Benzodiazepine receptorBZD siteGABA-A receptor allosteric siteOmega (ω) receptor

Positive allosteric modulation (PAM) that increases the frequency of chloride channel opening in the presence of GABA, thereby enhancing inhibitory postsynaptic potentials (Sigel & Steinmann, 2012; StatPearls, 2023).